查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198379

智能藥丸市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Smart Pills Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，智能藥丸市場預計將以 10.2% 的複合年增長率增長。

COVID-19 大流行增加了對用於管理 COVID-19 和其他相關疾病患者的智能藥丸的需求。 它還刺激了開發智能藥丸的研發活動。 例如，根據 2020 年 8 月發表在 International Journal on Emerging Technologies 上的一篇文章，在 COVID-19 大流行的時代，需要開發具有預編程功能的藥片供老年人和感染者使用。是一場比賽。 擬議的 PPD（預編程藥丸分配器）就是這樣一種方法，旨在讓他們定期服用藥丸。 根據上述消息來源，擬議的預編程藥物輸送系統設計有一個使用警報和攝像頭單元的警報模塊，旨在幫助患者定期服藥。就是這樣一種方法。 此外，根據世界衛生組織在 2022 年發表的一篇論文，小腸粘膜的宏觀變化，這在重症 COVID-19 患者中經常發生。 膠囊內窺鏡檢查是一種用於觀察小腸的微創方法，在 COVID-19 的情況下很有用。 因此，由於與智能藥丸相關的好處（例如提高效率），預計在大流行後階段供應商和患者的滿意度會提高。

推動智能藥丸市場增長的某些因素包括對微創設備的日益偏好、胃腸道疾病發病率的增加以及技術進步。 此外，神經系統疾病、癌症和其他疾病日益加重的負擔正在推動醫療環境中對智能藥丸的需求。 例如，世界衛生組織 2021 年 9 月更新估計，大約有 5500 萬人患有癡呆症，其中 60% 以上生活在低收入和中等收入國家。 同一份文件還報告說，這一數字預計到 2030 年將增加到 7800 萬，到 2050 年將增加到 1.39 億。 隨著阿爾茨海默病和癡呆症的增加，患者更容易忘記或錯誤服藥，從而增加了對智能藥丸的需求。 因此，全球疾病負擔的增加將導致對智能藥物輸送的需求增加，這最終將在預測期內推動智能藥丸市場的增長。

此外，根據 GIE Media, Inc. 於 2021 年 12 月發表的一篇文章，需要使用能見度和運動範圍有限的專用工具進行高技能運動，這促使外科團隊引入了更高水平的專業知識。 輔助設備包括內窺鏡照相機、可視化掃描儀和造影劑注射器。 根據2021年2月發表在IEEE Access上的一篇論文，微創醫學具有較低的術後並發症風險、較少的失血量、較短的術後恢復時間以及相關的生理組織創傷，具有體積小的重要臨床意義，已成為主流. 這些因素增加了患者對微創手術的偏好，導致智能藥丸市場的增長。

因此，上述因素共同歸因於所研究的市場在預測期內的增長。 然而，預計智能藥丸批准的嚴格法規和潛在的健康風險將阻礙預測期內的市場增長。

智能藥丸市場趨勢

預測期內膠囊內鏡有望高速增長

膠囊內窺鏡檢查是一種使用小型無線攝像頭拍攝消化道照片的程序。 膠囊內窺鏡攝像頭裝在一個維生素大小的膠囊中，您可以吞嚥。 當膠囊穿過消化道時，相機會拍攝數千張照片，並將它們發送到佩戴在腰帶上的記錄器中。 隨著醫療保健技術的進步，智能藥丸可以消除侵入性手術的需要。 智能藥丸以各種方式被設計出來，例如電池和機載內存的進步，增加了長期使用的重要性。 根據 Gastroenterology & Endoscopy News 2022 年 3 月發表的一篇文章，膠囊內鏡在評估 GI 出血方面具有較高的陽性（94%-97%）和陰性（83%-100%）預測價值，膠囊內鏡的結果可能導致內鏡37% 至 87% 的患者進行手術干預或改變醫療管理。 因此，由於內窺鏡領域的不斷發展和對胃腸道疾病準確診斷的需求不斷增加，預計所研究的市場在預測期內將出現顯著增長。

由於全球公司傾向於智能膠囊，預計該細分市場將呈現健康增長。 例如，Medtronic 提供 PillCam SB1、PillCam SB2、Olympus Endocapsule 和 Endocapsule 10，NaviCam stomach 由 Ankon 開發，而 CapsoCam 由 CapsoVision 在全球市場提供。 市場上的先進技術和產品批准也有望推動該領域的增長。 例如，2021 年 11 月，MEDTRONIC公司宣布美國食品和藥物管理局 (FDA) 批准用於遠程內窺鏡手術的 PillCam Small Bowel 3 系統。 此外，2022 年 7 月，蘇格蘭衛生研究人員將啟動一項耗資 600 萬歐元的新項目，使人工智能輔助 (AI) 膠囊內窺鏡成為未來腸癌診斷的一部分。 臨床膠囊內窺鏡檢查 (CCE) 使用一種包含攝像頭的“智能藥丸”，當患者吞服該攝像頭時，它會記錄通過腸道的圖像。

北美有望主導智能藥丸市場

北美已成為世界上最大的市場之一，原因包括廣泛接受先進的解決方案以簡化患者護理、龐大的客戶群以及快速增長的老年人口（據信佔大多數）。

此外，在專科藥品配送中，因人為行為導致的用藥錯誤越來越多。 因此，由於專注於為患者提供有價值的護理，預計美國對智能藥丸的需求將會增長。 例如，根據美國國家醫學圖書館發表的一篇文章，到 2022 年 7 月，僅美國每年就有 7,000 至 9,000 人死於用藥錯誤。 因此，這一統計數據表明，該國對智能藥丸產品的需求越來越大，以避免用藥錯誤。 此外，根據 2022 年阿爾茨海默病事實和數據報告，超過 600 萬所有年齡段的美國人患有阿爾茨海默病，到 2022 年，預計將有 650 萬 65 歲及以上的美國人患有阿爾茨海默病並與阿爾茨海默病共存。 根據同一數據，在美國 65 歲以上的總人口中，約有九分之一 (10.7%) 患有阿爾茨海默病。 阿爾茨海默病的患病率隨著年齡的增長而增加，在 65-74 歲的人群中達到 5.0%。 因此，從統計數據來看，美國對智能藥丸的需求預計會增長。

此外，智能藥丸設施的開發在美國正在增加，預計將引領市場。 例如，2022 年 3 月，AccelmedPartners 是一家專注於收購和投資美國商業階段、中低端市場 HealthTech 公司的私募股權公司，將推出完全集成的端到端藥房、藥物合規性，報告稱它已領導向領先的互聯醫療解決方案提供商 MedMinder Systems Inc 投資 4000 萬美元。

因此，預計上述因素將在預測期內推動該地區的市場增長。

智能藥丸市場競爭對手分析

由於公司在全球和區域開展業務，智能藥丸市場不景氣。 競爭格局包括CapsoVision、Check-Cap、etectRx Inc、HQ Inc、Kingsoft、Koninklijke Philips NV (Medimetrics)、Medtronic PLC、Olympus Medical Technology、Pentax Medical (Hoya)等市場份額較大的知名公司. 包括對少數國際和本地公司的分析

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 越來越喜歡微創設備
    • 增加消化系統疾病的負擔
    • 技術進步
  • 市場製約因素
    • 成本因技術進步而增加
    • 潛在的健康風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按應用領域
    • 膠囊內窺鏡檢查
      • 小腸視頻膠囊內窺鏡
      • 結腸膠囊內窺鏡檢查
    • 病人監護
    • 給藥
  • 疾病適應症
    • 不明原因的消化道出血
    • 克羅恩病
    • 小腸腫瘤
    • 乳糜瀉
    • 遺傳性息肉病綜合徵
    • 神經系統疾病
    • 其他適應症
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • CapsoVision Inc.
    • Medtronic PLC
    • Novartis AG
    • Olympus Medical Technology
    • Pentax Medical（Hoya）
    • Koninklijke Philips NV（Medimetrics）
    • CapsoVision Inc.
    • Check-Cap
    • Otsuka Pharmaceutical Co. Ltd
    • Intromedic
    • etectRx Inc.
    • Pixie Scientific
    • HQ Inc.
    • Jinshan Science and Technology

第七章市場機會與未來趨勢

簡介目錄
Product Code: 56614

The Smart Pills Market is expected to register a CAGR of 10.2% over the forecast period.

The COVID-19 pandemic has boosted the demand for smart pills for the management of patients suffering from COVID-19 and other associated disorders. It has also fueled the research and development activities for the development of smart pills. For instance, as per an article published by the International Journal on Emerging Technologies, in August 2020, in times of the COVID-19 pandemic, there was a need to develop a pill with a preprogrammed feature, which will be used by the elderly or infected people. The proposed preprogrammed pill dispenser (PPD) is one such approach that is designed to help them to take their medicines at regular intervals of time. As per the above-mentioned source proposed preprogrammed drug delivery system is designed with an alerting module using an alarm and camera unit, which is one such approach designed to help patients to take their medications at regular intervals of time. Additionally, according to an article published by WHO, in 2022, macroscopic changes in the small intestine mucosa, occurred frequently in severe COVID-19 patients. A minimally invasive alternative for studying the small intestine is the use of capsule endoscopy, which is useful in the context of COVID-19. Therefore, owing to the advantages associated with smart pills, such as improved efficiency, provider and patient satisfaction is anticipated to increase in the post-pandemic phase.

Certain factors that are driving the smart pills market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements. Additionally, the increasing burden of neurological, cancer, and other disorders is driving the demand for smart pills in healthcare settings. For instance, the World Health Organization, September 2021 update, around 55 million people have dementia, with over 60% living in low and middle-income countries. The same source also reports that this number is expected to rise to 78 million by 2030 and 139 million by 2050. With the increasing cases of Alzheimer's and dementia, there are increased chances of patients missing doses of medication or wrong administration leading to an increasing need for smart pills. Thus, the increasing burden of diseases around the globe lead to an increase demand for smart drug delivery eventually driving the growth of smart pill market over the forecast period.

Furthermore, according to an article published by GIE Media, Inc., in December 2021, the need to perform highly skilled actions using specialized tools with limited visibility and motion range has introduced higher levels of expertise for surgical teams. Support equipment includes endoscopic cameras, visualization scanners, contrast injectors, etc. According to an article published in IEEE Access in February 2021, minimally invasive medicine has become mainstream because of its crucial clinical significance in providing a low risk of postoperative complications, limited blood loss, short postoperative recovery time, and small sizes of associated physiological tissue wounds. These factors have led to an increased preference for minimally invasive surgeries among patients leading to the smart pills market growth.

Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However stringent regulations for the approval of smart pills and potential health risks are expected to hinder market growth over the forecast period.

Smart Pills Market Trends

Capsule Endoscopy is Expected to Witness High Growth Over the Forecast Period

Capsule endoscopy is a procedure that uses a tiny wireless camera to take pictures of your digestive tract. A capsule endoscopy camera sits inside a vitamin-size capsule you swallow. As the capsule travels through your digestive tract, the camera takes thousands of pictures that are transmitted to a recorder you wear on a belt around your waist. With the advent of healthcare technology, smart pills are capable of eliminating the need for invasive procedures. Various advances are being undertaken in smart pills, such as advances in batteries and onboard memory, which are making them significant for long-term usage. According to an article published by Gastroenterology & Endoscopy News, in March 2022, capsule endoscopy has a high positive (94%-97%) and negative (83%-100%) predictive value in the evaluation of GI bleeding, and findings on capsule endoscopy can lead to endoscopic or surgical intervention or a change in medical management in 37% to 87% of patients. Hence, it is anticipated that the market under study would experience significant growth over the forecast period due to ongoing developments in the field of endoscopy and the growing demand for accurate diagnoses of gastrointestinal illnesses.

Owing to the global companies inclining toward the smart capsule, the segment is expected to witness healthy growth. For instance, Medtronic provides PillCam SB1, PillCam SB2, Olympus provides Endocapsule and Endocapsule 10, NaviCam Stomach is developed by Ankon whereas, CapsoCam is provided by CapsoVision in the global markets. Advance technologies and product approvals in the market are also expected to drive segment growth. For instance, In November 2021, Medtronic plc announced the United States Food and Drug Administration (FDA) clearance for its PillCam Small Bowel 3 system for remote endoscopy procedures. Additionally, in July 2022, Scottish health researchers launched a new EUR 6 million project to make Artificial Intelligence-assisted (AI) capsule endoscopy a part of future bowel cancer diagnostics. Clinical Capsule Endoscopy (CCE) utilizes a 'smart pill' containing cameras that, once swallowed by a patient, records images of the intestines as it passes through.

North America is Expected to Dominate the Smart Pills Market

North America has dominated the global market studied, owing to the factors, such as the wide acceptance of technologically advanced solutions to make patient care hassle-free, a large pool of customers, and a rapidly growing geriatric population.

There is an increase in medication errors caused by human interaction in the distribution of specialty drugs. Thus, to focus on providing value-based care to patients in the United States the demand for smart pills is expected to grow. For instance, as per an article published by the National Library of Medicine, in July 2022, 7,000 to 9,000 persons each year in the United States alone die as a result of drug mistakes. Thus, the statistics indicate that there has been a rising need for smart pill products in the country to avoid medication errors. Additionally, as per the 2022 Alzheimer's Disease facts and figures report, more than 6 million Americans of all ages have Alzheimer's, and an estimated 6.5 million Americans aged 65 and older will be living with Alzheimer's in 2022. The same source reports that out of the total US population, about 1 in 9 people (10.7%) age 65 and older have Alzheimer's dementia. The percentage of people with Alzheimer's dementia increases with age, with 5.0% of people aged 65 to 74. Thus, the statistics indicate that the demand for smart pills is expected to rise in the United States.

Furthermore, the increase development of smart pill facilities in the United States is expected to drive the market. For instance, in March 2022, AccelmedPartners, a private equity firm, focused on acquiring and investing in the US commercial stage, lower middle market HealthTechcompanies, reported that it led a USD 40 million investment in MedMinder Systems Inc., the leading fully-integrated, end-to-end pharmacy, medication adherence, and connected care solution for elderly and polypharmacy patients.

Therefore, the factors mentioned above are expected to drive market growth in the region during the forecast period.

Smart Pills Market Competitor Analysis

The smart pills market is moderate due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including CapsoVision, Check-Cap, etectRx Inc., HQ Inc., Jinshan Science and Technology, Koninklijke Philips NV (Medimetrics), Medtronic PLC, Olympus Medical Technology, Pentax Medical (Hoya), among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally-invasive Devices
    • 4.2.2 Rising Burden of Gastrointestinal Disorders
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Increasing Cost with Technological Advancements
    • 4.3.2 Potential Health Risks
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application Area
    • 5.1.1 Capsule Endoscopy
      • 5.1.1.1 Small Bowel Video Capsule Endoscopy
      • 5.1.1.2 Colon Capsule Endoscopy
    • 5.1.2 Patient Monitoring
    • 5.1.3 Drug Delivery
  • 5.2 By Disease Indication
    • 5.2.1 Occult GI Bleeding
    • 5.2.2 Crohn's Disease
    • 5.2.3 Small Bowel Tumors
    • 5.2.4 Celiac Disease
    • 5.2.5 Inherited Polyposis Syndromes
    • 5.2.6 Neurological Disorders
    • 5.2.7 Other Disease Indications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 CapsoVision Inc.
    • 6.1.2 Medtronic PLC
    • 6.1.3 Novartis AG
    • 6.1.4 Olympus Medical Technology
    • 6.1.5 Pentax Medical (Hoya)
    • 6.1.6 Koninklijke Philips NV (Medimetrics)
    • 6.1.7 CapsoVision Inc.
    • 6.1.8 Check-Cap
    • 6.1.9 Otsuka Pharmaceutical Co. Ltd
    • 6.1.10 Intromedic
    • 6.1.11 etectRx Inc.
    • 6.1.12 Pixie Scientific
    • 6.1.13 HQ Inc.
    • 6.1.14 Jinshan Science and Technology

7 MARKET OPPORTUNITIES AND FUTURE TRENDS